Publication: 2660

Updated analysis of CALGB 100104 (Alliance): a randomised phase III study evaluating lenalidomide vs placebo maintenance after single autologous stem cell transplant for multiple myeloma
      QxMD      Google Scholar   
Citation:
Lancet Haematol vol 4 (9) e431-e442
Year:
2017
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Long-Term-Followup
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
7
Parents:
981   2263  
Children:
None
Program:
OGC
Primary Committee:
Myeloma
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U01HL069294, CA21115, CA31946, CA33601, U10CA004457, U10CA007968, U10CA016450, U10CA021060, U10CA032291, U10CA047559, U10CA059518, U10CA077298, U10CA077440, U10CA077651, U10CA077658, U10CA138561, U10CA180791, U10CA180799, U10CA180833, U10CA180838, U10CA180850, U10CA180858, U10CA180866, U10CA180867, U10 HL069294, U10 CA032291, U10 CA077658, U10 CA021115, U10 CA007968, U10 CA031946, U10 CA033601, U10 CA021060, U10 CA180821, U10 CA180858, U10 CA059518, U10 CA077440, U10 CA180791, U10 CA037447, U10 CA180850, U10 CA047559, U10 CA077651, U01 HL069294, U10 CA180882, U10 CA180820, U10 CA180833, U10 CA180799, U10 CA180867, U10 CA180838, U10 CA180866, U10 CA138561  
Corr. Author:
 
Authors:
                                                                             
Networks:
IL017, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-NY016, LAPS-NY158, LAPS-OH007, LAPS-UT003, LAPS-WI013, LAPS-WI020, MN022, NC002, NE003, NY018, NY021, NY141, SCOR, WV022   
Study
CALGB-100104
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Article